TrialLiver international : official journal of the International Association for the Study of the Liver2025

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.

Pietro Lampertico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.